diabetic peripheral neuralgia of lower limbs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)All patients fulfilled the diagnostic criteria for diabetes according to the American Diabetes Association in 2016, and glycosylated hemoglobin (HbA1c) 4 points; (7) No treatments, such as radiofrequency and electrical stimulation, that may have affected the results of the study were given in the last month; (8) Agreed to sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Serious systemic diseases such as uncontrolled hypertension or diabetes, and cardiac dysfunction (New York Heart Association grade II–III); (2) A history of psychiatric disease; (3) Patients with infectious diseases, infection at the puncture site; (4) The investigator believes that the patient has a medical history that may confuse the study results or present other additional risks; (5) Severe coagulation dysfunction; (6) Refuse to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| he total effective rate and significant effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tramadol and pregabalin remedial dose;Adverse reactions;SF-36;Numerical Rating Scale;Peak systolic flow velocity of both lower limb arteries;Skin temperature of lower limbs;Tip perfusion index; | — |
Countries
China
Contacts
Fujian Provincial Hospital